[Federal Register Volume 61, Number 62 (Friday, March 29, 1996)]
[Notices]
[Page 14107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-7724]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Division of Research Grants; Notice of Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Division of Research Grants Special Emphasis Panel (SEP) meetings:

    Purpose/Agenda: To review individual grant applications.
    Name of SEP: Clinical Sciences.
    Date: April 11, 1996.
    Time: 1:00 p.m.
    Place: NIH, Rockledge 2, Room 4216, Telephone Conference.
    Contact Person: Dr. Harold Davidson, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 4216, Bethesda, Maryland 
20892, (301) 435-1776.
    Name of SEP: Biological and Physiological Sciences.
    Date: April 12, 1996.
    Time: 2:00 p.m.
    Place: NIH, Rockledge 2, Room 6168, Telephone Conference.
    Contact Person: Dr. Syed Amir, Scientific Review Administrator, 
6701 Rockledge Drive, Room 6168, Bethesda, Maryland 20892, (301) 
435-1043.

    Name of SEP: Microbiological and Immunological Sciences.
    Date: April 12, 1996.
    Time: 1:00 p.m.
    Place: NIH, Rockledge 2, Room 4210, Telephone Conference.
    Contact Person: Dr. Bruce A. Maurer, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 4210, Bethesda, Maryland 
20892, (301) 435-1225.

    Name of SEP: Microbiological and Immunological Sciences.
    Date: April 12, 1996.
    Time: 3:00 p.m.
    Place: NIH, Rockledge 2, Room 4210, Telephone Conference.
    Contact Person: Dr. Bruce A. Maurer, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 4210, Bethesda, Maryland 
20892, (301) 435-1225.

    This notice is being published less than 15 days prior to the above 
meetings due to the urgent need to meet timing limitations imposed by 
the grant review and funding cycle.
    Name of SEP: Microbiological and Immunological Sciences.
    Date: April 16, 1996.
    Time: 1:00 p.m.
    Place: NIH, Rockledge 2, Room 4194, Telephone Conference.
    Contact Person: Dr. Sami Mayyasi, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 4194, Bethesda, Maryland 
20892, (301) 435-1216.

    Name of SEP: Biological and Physiological Sciences.
    Date: April 23, 1996.
    Time: 1:00 p.m.
    Place: NIH, Rockledge 2, Room 4148, Telephone Conference.
    Contact Person: Dr. Philip Perkins, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 4148, Bethesda, Maryland 
20892, (301) 435-1718.

    Name of SEP: Chemistry and Related Sciences.
    Date: April 24, 1996.
    Time: 8:30 a.m.
    Place: Ramada Inn, Bethesda, MD.
    Contact Person: Dr. Asher Hyatt, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 4160, Bethesda, Maryland 
20892, (301) 435-1724.

    Name of SEP: Clinical Sciences.
    Date: April 25, 1996.
    Time: 2:00 p.m.
    Place: NIH, Rockledge 2, Room 4106, Telephone Conference.
    Contact Person: Ms. Josephine Pelham, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 4106, Bethesda, Maryland 
20892, (301) 435-1786.

    Name of SEP: Clinical Sciences.
    Date: April 30, 1996.
    Time: 10:00 a.m.
    Place: NIH, Rockledge 2, Room 4138, Telephone Conference.
    Contact Person: Dr. Anthony Chung, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 4138, Bethesda, Maryland 
20892, (301) 435-1213.

    Purpose/Agenda: To review Small Business Innovation Research.
    Name of SEP: Behavioral and Neurosciences.
    Date: April 20, 1996.
    Time: 8:30 a.m.
    Place: Embassy Suites, Ft. Lauderdale, FL.
    Contact Person: Dr. Samuel C. Rawlings, Scientific Review 
Administrator, 6701 Rockledge Drive, Room 5160, Bethesda, Maryland 
20892, (301) 435-1243.
    The meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Nos. 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 25, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-7724 Filed 3-28-96; 8:45 am]
BILLING CODE 4140-01-M